Kyle Okamuro
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (11)
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Background Sexual function is a crucial factor in achieving optimal sexual health and is typically assessed by one’s ability to achieve desire, arousal and orgasm. The majority of genital gender-affirming surgery literature has focused on urologic or esthetic outcomes, with less emphasis on sexual function. Aim We sought to systematically review studies assessing sexual health outcomes of phalloplasty in the transmasculine population to elucidate our current understanding of the range of sexual health outcomes studied and to identify knowledge gaps. Methods Studies on sexual function in transmasculine patients were systematically identified using PubMed, Embase, and Web of Science searches from database origins through February 29, 2024 based on the Preferred Reporting Items for Systematic Reviews and Meta-Analysis statement. Results Eighteen articles met the criteria for inclusion. Arousal/desire outcomes ranged from 5.4% of patients with difficulty with arousal to 77% of patients with reduced arousal to half the time or less. Studies varied widely in assessment, but the majority reported ratings of erogenous sensation to be between 53% and 100%. The ability to orgasm ranged from 50%–93% during masturbation, 58%–75% during intercourse with a partner, and 29%–100% when asked generally. The ability to engage in penetrative intercourse ranged between 19% and 100%, and often included people who had not received penile implants. The absence of pre-surgical data limits our ability to assess whether the reported post-operative outcomes reflect an improvement in sexual health. Conclusion This review revealed differences in sexual function based on phalloplasty technique. Specifically, the largest post-op increase in desire was after radial forearm free flap (RFFF). Roughly half of patients who underwent phalloplasty with either RFFF or suprapubic pedicle reported the ability to achieve orgasm. Most patients reported penetrative ability with a penile implant, though patients did endorse penetration without an implant. Future studies are needed with outcome measures that have been validated within the transmasculine population and with more granular information regarding ancillary procedures, donor sites, and type of nerve coaptation.
Year:
2025
Objectives: This study aims to advance patient safety science by identifying and addressing the systemic causes of psychosocial harm among transgender and gender nonbinary (TGNB) individuals. The 4-year TRANS-SAFE patient safety learning laboratory (PSLL) will follow a 6-phase systems engineering approach to study ways to improve the safety of TGNB patients. Methods: This study involves conducting a systematic scoping review, interviews with patients, providers, and community members, and observations of TGNB patient and provider experiences to identify determinants of avoidable patient suffering. In addition, the PSLL will provide financial support for pre-doctorate and post-doctorate research scholars in the TGNB community. Human-centered solutions will be co-designed to mitigate psychosocial harm among TGNB individuals. Interventions will be developed through engagement with stakeholders in an iterative process of co-design and evaluation. Results: Interventions will be evaluated in real and simulated clinical environments for effectiveness, acceptability, usability, feasibility of implementation, and sustainability. A structural innovation of this PSLL is its focus on sustainment and dissemination, which will be facilitated through the development of a TRANS-SAFE certification process for health care organizations in partnership with the World Professional Association for Transgender Health (WPATH). Conclusions: This PSLL will address a fundamental gap in the science and practice of patient safety by assessing and addressing psychosocial patient harm in a high-risk population that has been too often neglected in the patient safety literature.
Year:
2025
Purpose Misgendering of transgender and non-binary (TGNB) individuals in healthcare settings can lead to worsened mental and physical health outcomes and decreased utilisation of care. Few studies have investigated the factors that contribute to this phenomenon. The purpose of this study was to apply qualitative methods to explore sources of misgendering, its perceived impact, prevention strategies and clinician responses to accidentally misgendering a patient, as identified by TGNB patients and gender-affirming care clinicians. Methods Between April and June 2022, 20 semi-structured interviews were performed at an academic medical centre in Southern California. Participants were recruited via purposive sampling and included: (1) TGNB patients (n=8) recruited from an interdisciplinary gender-affirming urological practice and (2) gender-affirming care clinicians (n=12) recruited from a regional interdisciplinary Gender Health conference, three of whom identified as TGNB. Interviews were conducted in person or virtually using an open-ended topic guide, audio recorded and transcribed verbatim. Inductive thematic analysis was performed by two independent study personnel who hand-coded the transcripts. Results Four overarching themes were identified: (1) misgendering originates from multiple sources, (2) misgendering discourages individual access to healthcare, creates community hesitation and its perceived impact is modified by setting and intentionality, (3) building a gender-affirming healthcare system requires integration of behaviour, policy and technology and (4) clinicians respond to accidental misgendering by acknowledging, apologising, advancing and acting. Conclusion Our data suggest that misgendering arises from both interpersonal communication and structural factors within healthcare systems, leading to perceived harm and diminished TGNB access to health services. Any potential solution to reduce this phenomenon will require a multifaceted approach integrating behavioural, technological and institutional policy strategies with system-level implementation efforts.
Year:
2025
Year:
2025
Background Gender-affirming medical therapy (GAMT), including puberty blockers (PB) and gender-affirming hormone therapy (GAHT), is part of the transition for many transgender and nonbinary (TGNB) individuals; however, there have been few studies investigating sexual function and desire during GAMT, and no reports on individuals who received PB. Aim We aimed to qualitatively evaluate the sexual experience of TGNB individuals during GAMT and identify significant and consistent themes that arose from our analysis. Methods We performed an Institutional Review Board-approved two-institutional study. Our study group (n = 63) included individuals who had received or were receiving puberty blockers (GnRHa) and/or GAHT (estrogen or testosterone) at the time of enrollment. Outcomes The enrolled subjects were interviewed using an open-ended topic-based guide, and qualitative analysis was performed by hand coding the interview transcripts using Constructivist Grounded Theory qualitative methods until thematic saturation was reached. Results A total of 63 TGNB subjects (33 transgender women, 20 transgender men, 10 non-binary, or another gender identity), aged 18-25 years, were interviewed about the effect of GAMT on their sexual function and desire. Our analysis uncovered several themes that were consistent among subjects from different subgroups. Half the participants reported feeling no regrets regarding GAMT therapy, and the other half reported that they wished they had started GAMT sooner. Two notable themes were identified: many subjects reported “less dysphoria” as a positive change in sexual desire, and others reported more enjoyable sexual experiences since being on GAMT. The subgroup of subjects with a history of GnRHa use did not differ in their experiences and responses from the subgroup on GAHT alone, which indicated no negative effect of GnRHa on sexual function. Clinical Implications Our results illuminate the need for providers to discuss the potential impacts of GAMT on sexual function and desire with transgender and nonbinary patients. Strengths & Limitations An important strength of this study is the open-ended interview design. This design allowed subjects to speak freely and openly about their experience. One limitation is a relatively small sample size, particularly of the puberty blocker (GnRHa) subgroup. A more robust sample is needed to further investigate the effect of GAMT on sexual function and desire in TGNB individuals, specifically those receiving GnRHa. Conclusion Themes were similar for all subjects; however, the most prominent theme among our subjects was that the positive changes in sexual function and desire outweighed any negative changes.
Year:
2025
Introduction Numerous studies have evaluated urologic and aesthetic outcomes of genital gender affirming surgery. However, minimal data exist on sexual function of transmasculine individuals after genital gender affirming surgery, and studies often aggregate outcomes from different techniques. This paper aims to systematically review the literature on sexual health outcomes following metoidioplasty surgery. Objectives To synthesize and analyze the literature on sexual health following metoidioplasty, to identify areas of further investigation, and to improve shared decision making and sexual outcomes following metoidioplasty. Methods Studies were systematically identified using PubMed, Embase, and Web of Science from database origins through July 30, 2025, in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analysis statement. Included sexual health outcomes were desire/arousal, sensation, orgasm, masturbation, erection, penetrative capacity, sexual activity, and sexual satisfaction. Studies were screened independently by two authors and reviewed by four authors for eligibility. Disagreements were decided between three authors, including a sexual health expert and a gender affirming surgeon. Quality assessment was done using the Newcastle-Ottawa Scale. Results Twenty-three papers met inclusion criteria. All studies used ad-hoc questionnaires, and the majority did not primarily assess sexual health. Arousal/desire, preservation of erogenous sensation, and masturbation received high ratings (85+%). Erectile function scores were high (94+%), despite one outlier study (20%). Orgasm outcomes were mixed (66%-100%). Ability for penetrative intercourse was generally low (0%-24%), with one outlier study (70%). Overall sexual satisfaction was moderate-high (53%-88%). Conclusions Metoidioplasty appears to have largely satisfactory sexual health outcomes if penetrative sex is not a priority. Potential areas of further research include phallus lengthening protocols, PDE5 inhibitors (eg, Viagra), intracavernosal injections, and insertion of penile prostheses. Future studies are needed that include larger populations, are transparent regarding selection criteria and baseline anatomy, use standardized outcome measures, and investigate these complex outcomes from a person-centered, holistic approach.
Year:
2025
Year:
2024
Collaborators (4)
Maja Marinkovic
Clinical Professor
University of California, San Diego
Andres Schneeberger
HS Clinical Professor
University of California, San Diego
Priya Lewis
Assistant Clinical Professor
University of California, San Diego
Alan Card
Assistant Professor
San Diego State University
Make your next move.
Prepare your application
Review drafts before you send them.